Induction triplet chemotherapy in patients with rectal adenocarcinoma and synchronous metastases, an AGEO-FFCD study

Autor: Dabout, Victoire ^{a, ⁎}, Mineur, Laurent ^b, Tougeron, David ^c, Malicot, Karine Le ^d, Gallois, Claire ^e, Phelip, Jean Marc ^f, Turpin, Anthony ^g, Cohen, Romain ^h, Demoustier, Benedicte ⁱ, Hautefeuille, Vincent ^j, Locher, Christophe ^k, Levaché, Charles-Briac ^l, Mitry, Emmanuel ^m, Lecomte, Thierry ⁿ, Brocard, Fabien ^o, Hassid, Deborah ^p, Porte, Marie ^q, Breysacher, Gilles ^r, Lagasse, Jean-Paul ^s, Lepage, Côme ^t, Valéry, Marine ^u, Bachet, Jean-Baptiste ^{a, ⁎}

Publikováno v: In Clinics and Research in Hepatology and Gastroenterology January 2025 49(1)

PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer

Autor: Evrard, Camille, Louvet, Christophe, Hajbi, Farid EL, Fiore, Frédéric DI, Malicot, Karine LE, Aparicio, Thomas, Bouché, Olivier, Laurent-Puig, Pierre, Bibeau, Frédéric, Lecomte, Thierry, Lièvre, Astrid, Guimbaud, Rosine, Kim, Stefano, Zaanan, Aziz, Sokol, Harry, Chibaudel, Benoist, Desrame, Jérome, Pierre, Sabrina, Gonzalez, Daniel, Lepage, Come, Tougeron, David

Publikováno v: In Digestive and Liver Disease April 2021 53(4):420-426

Additional file 1 of Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer

Autor: Guilloteau, Adrien, Abrahamowicz, Michal, Olayide Boussari, Jooste, Valérie, Aparicio, Thomas, Quantin, Catherine, Malicot, Karine Le, Binquet, Christine

Additional file 1: Appendix 1. Additional information about the method used for testing linearity and proportional hazards hypotheses. Appendix 2. Directed Acyclic Graph. Appendix 3. Flow-chart. Appendix 4. Comparison of included and excluded patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45d70b186e232d6e3862b5e5ca0ca677

Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma.

Autor: Canton, Clémence, Boussari, Olayidé, Boulin, Mathieu, Malicot, Karine Le, Taieb, Julien, Dahan, Laetitia, Lopez, Anthony, Lepage, Come, Bachet, Jean-Baptiste

Publikováno v: Oncologist; Jul2022, Vol. 27 Issue 7, pe571-e579, 9p, 1 Diagram, 4 Charts, 1 Graph

Induction triplet chemotherapy in patients with rectal adenocarcinoma and synchronous metastases, an AGEO-FFCD study.

Autor: Dabout V; Sorbonne University, Hepato-gastroenterology and digestive oncology department, Pitié Salpêtrière hospital, APHP, Paris, 47-83 Boulevard de l'hôpital, Paris 75013, France. Electronic address: victoire.dabout@aphp.fr., Mineur L; Department of Radiotherapy and Medical Oncology, Sainte-Catherine Institute, Avignon, France., Tougeron D; Department of Gastroenterology and Hepatology, Centre Hospitalo-universitaire de Poitiers, Poitiers, France., Malicot KL; Fédération Francophone de Cancérologie Digestive, Dijon, France., Gallois C; Department of Gastroenterology and Digestive Oncology, European Georges Pompidou hospital, Paris, France., Phelip JM; University Hospital of Saint Etienne, Saint Etienne, France; Unité HESPER EA-7425 Université Jean Monnet/Claude Bernard Lyon 1, France., Turpin A; Medical Oncology Department, University hospital, Lille, France and University of Lille, Lille, France., Cohen R; Sorbonne University, Department of Oncology, Saint-Antoine Hospital, INSERM 938, SIRIC CURAMUS, Paris, France., Demoustier B; Univ. Grenoble Alpes / Hepato-Gastroenterology and Digestive Oncology department, CHU Grenoble Alpes / Institute for Advanced Biosciences, CNRS UMR 5309-INSERM U1209, Grenoble, France., Hautefeuille V; Departments of Hepatogastroenterology and Digestive Oncology, CHU Amiens Picardie, Amiens, France., Locher C; Department of Hepato-gastroenterology and Digestive Oncology, Meaux Hospital, France., Levaché CB; Département d'Oncologie Médicale, Clinique Francheville, Périgueux, France., Mitry E; Medical Oncology department, Institut Paoli-Calmettes, Marseille, France., Lecomte T; Department of Hepatogastroenterology and Digestive Oncology, Hôpital Trousseau, CHRU de Tours, 37044 Tours Cedex 09, UMR INSERM U 1069, Université de Tours, 10 Boulevard Tonnellé, Tours 37000, France., Brocard F; GINECO and Centre Oncologie de Gentilly, Nancy, France., Hassid D; Gastroenterology Department, AP-HP, Hôpital Saint-Louis/Lariboisière, Paris, France., Porte M; Department of Medical Oncology, Centre Hospitalier Universitaire Nantes, Nantes University, Nantes, France., Breysacher G; Gastroenterology Department, CH Pasteur, Colmar, France., Lagasse JP; Department of Gastroenterology, Hepatology and digestive Oncology, Centre Hospitalo-universitaire d'Orleans, Orleans, France., Lepage C; Burgundy Digestive Cancer Registry, INSERM U866, Dijon Cedex 21079, France. Electronic address: come.lepage@u-bourgogne.fr., Valéry M; Medical Oncology Department, Gustave Roussy, Villejuif F-94805, France., Bachet JB; Sorbonne University, Hepato-gastroenterology and digestive oncology department, Pitié Salpêtrière hospital, APHP, Paris, 47-83 Boulevard de l'hôpital, Paris 75013, France. Electronic address: jean-baptiste.bachet@aphp.fr.

Publikováno v: Clinics and research in hepatology and gastroenterology [Clin Res Hepatol Gastroenterol] 2024 Dec 12; Vol. 49 (1), pp. 102514. Date of Electronic Publication: 2024 Dec 12.